Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions, today announced that the U.S. Food and Drug ...
Sciatica is one of the more common ailments affecting human beings. Present in up to 40% of individuals at some point in their lifetime and in as many as 5% at any given time, the societal ...
Add Yahoo as a preferred source to see more of our stories on Google. You've likely heard of sciatica before. The shooting pain that runs down your lower back, buttocks and leg can disrupt your daily ...
Consano Bio receives US FDA IND clearance to expand the C-1101 chronic sciatica clinical development programme into US: Burlington, Massachusetts Tuesday, July 21, 2026, 14:00 Hrs ...
Dear Doctor K: I suffer from sciatica, which has caused a lot of pain over the past six month. My doctor has recommended epidural injections, but I hear that they have been disproven. Can you help me ...
FDA IND clearance enables U.S. site activation for the ongoing Phase I C-1101-101 trial, with initial dosing already completed in Australia and near-term plans to begin treating U.S. patients. C-1101 ...